UroGen Pharma
Katerina Shamalov, PhD, currently serves as Preclinical Research Manager at UroGen Pharma since May 2022. Prior to this role, Katerina held positions at 4C Biomed from December 2017 to June 2022, where responsibilities included Project Manager and Team Lead. Katerina also completed a PhD in Immunology and Immunotherapy of cancer at Bar-Ilan University, where academic involvement spanned from January 2014 to September 2018.
This person is not in any offices
UroGen Pharma
UroGen Pharma is a biopharmaceutical company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options.